Therefore, CMTM8 acts as an attenuator of EGF-induced signaling by facilitating ligand-induced EGFR endocytosis and subsequent desensitization, indicating that the alteration of CMTM8 levels in cancer might affect EGFR signaling. Here, EGFR is linked to cancer.